Instrument Inactif

Communiqués Masimo Corporation Sao Paulo

Actions

M2AS34

BRM2ASBDR009

Equipement, fournitures et distribution médicale

Communiqués

07/05	Court Of Chancery Enforces Non-Delaware Choice Of Forum In Corporate Governance Contract, Finding Legislature Overrode Key Judicial Precedents	AQ
06/05	Masimo : Quarterly Report for Quarter Ending April 4, 2026 (Form 10-Q)	PU
04/05	Masimo Shareholders Approve Acquisition by Danaher	BU
30/04	L’oxymétrie de pouls Masimo SET® s’est révélée précise chez les nouveau-nés hospitalisés de toutes les couleurs de peau dans le cadre de la plus grande étude prospective jamais menée en conditions réelles	BU
28/04	Masimo SET® Pulse Oximetry Performed Accurately on Hospitalized Newborns of All Skin Tones in Largest-Ever Prospective Real-World Study	BU
08/04	Masimo Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Masimo Corporation - MASI	BU
19/03	Are ACLX, MASI, FONR Obtaining Fair Deals for their Shareholders?	PR
16/03	Are MASI, ACLX, GLDD Obtaining Fair Deals for their Shareholders?	PR
27/02	BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Masimo Corporation (Nasdaq – MASI), IHS Holding Limited (NYSE – HIS), VerifyMe, Inc. (Nasdaq – VRME), Great Lakes Dredge & Dock Corporation (Nasdaq – GLDD)	AQ
19/02	Masimo Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Masimo Corporation - MASI	BU
17/02	BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Masimo Corporation (Nasdaq - MASI), IHS Holding Limited (NYSE – HIS), VerifyMe, Inc. (Nasdaq - VRME), Great Lakes Dredge & Dock Corporation (Nasdaq - GLDD)	AQ
17/02	MASI Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Masimo Corporation to Danaher Corporation	AQ
17/02	Danaher To Acquire Masimo Corporation	PR
12/02	Masimo to Report Fourth Quarter and Full Year 2025 Financial Results after Market Close on Thursday, February 26	BU
12/01	Masimo Announces Select Preliminary 2025 Financial Results	BU
07/01	Masimo to Present in the J.P. Morgan 2026 Healthcare Conference	BU
05/12	HALPER SADEH LLC ENCOURAGES MASIMO CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS	PR
03/12	Masimo Hosts 2025 Investor Day and Details Strategic Roadmap for Durable Growth	BU
18/11	Knobbe Martens Guides Masimo to $634M Win Against Apple in Patent Infringement Case	PR
15/11	Masimo Issues Statement on California Jury Verdict Finding Patent Infringement by Apple and Awarding Masimo $634 Million in Damages	BU
04/11	Masimo : Q3 2025 Supplemental Presentation to Earnings Press Release	PU
04/11	Masimo: Q3 Earnings Snapshot	AQ
04/11	Masimo Reports Third Quarter 2025 Results	BU
21/10/25	Masimo to Report Third Quarter 2025 Financial Results after Market Close on Tuesday, November 4	BU
09/10/25	Masimo to Host Investor Day on December 3, 2025	BU